Form 4: Tenet Healthcare CEO Saumya Sutaria Reports Stock Transactions

CEO Saumya Sutaria reports acquisition and disposal of Tenet Healthcare stock and derivative securities related to vesting of restricted stock units.

Summary

• On February 28, 2025, Saumya Sutaria, CEO of Tenet Healthcare Corp, acquired 22,416 shares of common stock through the vesting of restricted stock units.
• Additionally, 36,384 shares were acquired through the vesting of other restricted stock units on the same date.
• On March 3, 2025, 31,076 shares were withheld for payment of taxes upon vesting of restricted stock units at a price of $126.59.
• Following these transactions, Sutaria directly owns 368,683 shares of Tenet Healthcare Corp.
• Sutaria also owns 44,834 restricted stock units from the 2024 grant and 36,384 restricted stock units from the 2023 grant.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing stock transactions by an executive, with no inherent positive or negative sentiment.

Positives

• The vesting of restricted stock units indicates a long-term incentive for the CEO aligned with the company's performance.

Industry Context

Form 4 filings are standard practice for reporting insider transactions and provide transparency to investors regarding the actions of company executives.

Comparison to Industry Standards

• Executive compensation packages often include restricted stock units that vest over time, aligning executive interests with shareholder value, a common practice among publicly traded healthcare companies such as HCA Healthcare and Universal Health Services.
• The vesting schedules of 1/3 increments annually are typical for such grants.

Stakeholder Impact

• The transactions provide transparency to shareholders regarding executive compensation and stock ownership.

Key Dates